MSInsight
Created in 2022
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,768Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 7
SIREN
910844729Engaged corporates
37
6 36Added in Motherbase
1 year, 10 months ago
healthtech Value proposition
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Microsatellite Instability, Next-Generation Sequencing, Diagnostic Test, Bioinformatics, Oncology, Precision Medicine, Hereditary Cancer, and Defective Mismatch RepairOriginal language
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
MSInsight - Harnessing genomic data for better cancer care
Empowering precision oncology by unlocking insights on MSI via Next-Generation Sequencing for better tumor biomarker diagnosis and improved patient care.
https://www.msinsight.tech/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Hello Tomorrow Trade show, Business Consulting and Services | Hello Tomorrow Trade show, Business Consulting and Services | Other 14 Nov 2024 | | |
 Maddyness Media, Media Production | Maddyness Media, Media Production | Other 21 Jun 2024 | | |
 Illumina Biotechnology, Biotechnology Research | Illumina Biotechnology, Biotechnology Research | Other 21 Aug 2024 | | |
 Viva Technology Trade show, IT Services and IT Consulting | Viva Technology Trade show, IT Services and IT Consulting | Other 26 May 2024 | | |
 Publicis Groupe Advertising, Advertising Services | Publicis Groupe Advertising, Advertising Services | Other 26 May 2024 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 13 Mar 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 3 Dec 2024 | | |
 ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | Other 23 Apr 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 16 Sep 2024 | | |
 | Gouvernement | Other 21 Jun 2024 | | |